403
Sorry!!
Error! We're sorry, but the page you were looking for doesn't exist.
Hims & Hers Opens Up Pre-Launch Waitlist For Ozempic And Wegovy Following Partnership With Novo Nordisk
(MENAFN- AsiaNet News)
Hims & Hers Health Inc. (HIMS) on Wednesday announced a pre-launch waitlist for Ozempic and Wegovy following a partnership with Novo Nordisk AS (NVO).
Hims & Hers stated that people who sign up for the waitlist will gain priority access to the official debut of Ozempic and Wegovy on the telehealth company's platform.
Interested users can join the waitlist here or here.
Hims & Hers shares were down nearly 1% in Wednesday's pre-market trade. Retail sentiment on Stocktwits around the company trended in the 'bullish' territory with message volumes at 'high' levels at the time of writing.
Get updates to this story developing directly on Stocktwits.
For updates and corrections, email newsroom[at]stocktwits[dot]com.
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research
More Story
Comments
No comment